Utility of TOFCuff at the time of the general anesthesia operation, monitoring anesthesia maintenance, degree of the line relaxation at the time of the extubation at the time of anesthesia introduction and weigh it against an evaluation in conventional TOF-Watch.

Basic objectives2

Efficacy

Basic objectives -Others

Trial characteristics_1

Trial characteristics_2

Developmental phase

Assessment

Primary outcomes

Correlation of the line relaxation monitoring in TOF-Watch and TOFCuff

Key secondary outcomes

Having or not early post operation respiratory dysfunction

Base

Study type

Interventional

Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know

Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

measuring TOF count before administration of rocuronium

Interventions/Control_2

After administration rocuronium, measuring TOF count or TOF ratio in parallel in TOFCUff and TOF-Watch every 30 seconds

Interventions/Control_3

After the operation, measuring similarly administration of sugammadex

Interventions/Control_4

Interventions/Control_5

Interventions/Control_6

Interventions/Control_7

Interventions/Control_8

Interventions/Control_9

Interventions/Control_10

Eligibility

Age-lower limit

15

years-old

<=

Age-upper limit

80

years-old

>=

Gender

Male and Female

Key inclusion criteria

The patient who it is a state of ASA-PS 1-2, and does not correspond to exclusion criteria

Key exclusion criteria

Patient younger than 15 years
Patient having a neuromuscular disease
Patient having a renal function disorder
Patient having a liver function disorder
Patient thought to be the skin state having difficulty in line relaxation monitoring
The patient whom a study representative or an allotment researcher judged not to be able to evaluate it who it is not cooperative or is enough after a study start during a period until leaving
In addition, the patient who judged that a study representative or an allotment researcher was inappropriate